Dimensional Fund Advisors’s Antares Pharma, Inc. ATRS Stock Holding History

Dimensional Fund Advisors’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,929,239	Closed	-$7.91M	–	3577
2022 Q1	$7.91M	Buy	1,929,239 +332,967	+21%	+$1.21M	﹤0.01%	2385
2021 Q4	$5.7M	Sell	1,596,272 -75,222	-5%	-$263K	﹤0.01%	2523
2021 Q3	$6.08M	Buy	1,671,494 +255,995	+18%	+$1.04M	﹤0.01%	2522
2021 Q2	$6.17M	Buy	1,415,499 +463,325	+49%	+$1.89M	﹤0.01%	2544
2021 Q1	$3.91M	Buy	952,174 +529,921	+125%	+$2.3M	﹤0.01%	2656
2020 Q4	$1.69M	Buy	422,253 +163,000	+63%	+$527K	﹤0.01%	2852
2020 Q3	$700K	Buy	259,253 +107,157	+70%	+$297K	﹤0.01%	3002
2020 Q2	$418K	Buy	+152,096	New	+$424K	﹤0.01%	3109

Other funds holding ATRS

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Dimensional Fund Advisors's ATRS Position: Q2 2022 in Review

Dimensional Fund Advisors sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 1,929,239 shares — an estimated $7.91M sold.

Dimensional Fund Advisors first reported a position in ATRS in Q2 2020 and held it in 8 quarters. The position peaked at $7.91M in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Dimensional Fund Advisors reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Dimensional Fund Advisors sold 1,929,239 Antares Pharma, Inc. shares in Q2 2022, an estimated $7.91M.
Dimensional Fund Advisors first reported a position in Antares Pharma, Inc. in Q2 2020 and held it in 8 quarters.
Dimensional Fund Advisors's Antares Pharma, Inc. position peaked at $7.91M in Q1 2022.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Dimensional Fund Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.